Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Lung Cancer (Amsterdam, Netherlands)|September 5, 2022
Rare EGFR E709-T710delinsX: Molecular characteristics and superior response to afatinib treatment in NSCLC patientsYihua Huang, Chunwei Xu, Yuanliang Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2021
Pyrotinib in Patients with HER2-Amplified Advanced Non-Small Cell Lung Cancer: A Prospective, Multicenter, Single-Arm TrialZhengbo Song, Dongqing Lv, Shi-Qing Chen, et al.
Signal Transduction and Targeted Therapy|November 3, 2024
First-in-human, phase 1 dose-escalation and dose-expansion study of a RET inhibitor SY-5007 in patients with advanced RET-altered solid tumorsWei Li, Yongsheng Wang, Anwen Xiong, et al.
Frontiers in Oncology|April 13, 2023
A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinomaYongwei Chen, Yanyun Zhu, Yuanmei Dong, et al.
Experimental Hematology & Oncology|May 9, 2026
Inhibition of protein kinase CK2 remodels the tumor immune microenvironment and sensitizes lung cancer to PD-L1 blockadeSijia Zhang, Lihua Luo, Yangang Qu, et al.
Lung Cancer (Amsterdam, Netherlands)|July 30, 2023
Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective studyJiayan Chen, Chunwei Xu, Qian Wang, et al.
Translational Lung Cancer Research|March 15, 2021
A large real-world cohort study of examined lymph node standards for adequate nodal staging in early non-small cell lung cancerZhihua Zhu, Zhengbo Song, Wenjie Jiao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 9, 2021
Deep RNA Sequencing Revealed Fusion Junctional Heterogeneity May Predict Crizotinib Treatment Efficacy in ALK-Rearranged NSCLCZhengbo Song, Shifeng Lian, Silvia Mak, et al.
Pageof 15